Abstract
Thrombocytopenia is a frequent complication of cirrhosis. Its pathogenesis is not well known, but it has been suggested that splenic congestion induced by portal hypertension may be a major contributory factor. However, the available data regarding the effect of portal decompression either by surgical shunts or transjugular intrahepatic portosystemic shunt (TIPS) on peripheral platelet count in cirrhotics is conflicting. We studied the effects of TIPS on platelet count and mean platelet volume, following a successful TIPS placement. The platelet count had a tendency to decrease but was not statistically significant (120,100 ± 72,100/mm3 before TIPS vs 99,800 ± 51,400/mm3 after TIPS). The mean platelet volume remained essentially unchanged (9.8 ± 1.5 fL before TIPS and 9.9 ± 1.5 fL after TIPS). These results confirm that TIPS has an unpredictable effect on platelet count in cirrhotic patients with thrombocytopenia. The lack of a consistent increase in the peripheral mean platelet volume following TIPS placement suggests that TIPS is unable to significantly enhance the release of platelets sequestered in the splenic compartment in portal hypertension.
Similar content being viewed by others
REFERENCES
Morlock CG, Hall BE: Association of cirrhosis, thrombocytopenia and hemorrhagic tendency. Arch Intern Med 72:69-77, 1943
Felix WR, Myerson R, Sigel B, Perrin E, Jackson F: The effect of portocaval shunt on hypersplenism. Surg Gynecol Obstet 139:899-903, 1989
Soper NJ, Nikkers LF: Effect of operations for variceal hemorrhage on hypersplenism. Am J Surg 144:700-703, 1982
Morris PW, Patton TB, Balint JA, Hirschowitz BI: Portal hypertension, congestive splenomegaly, and portocaval shunt. Gastroenterology 42:555-559, 1962
Mutchnick M, Lerner E, Conn H: Effect of portocaval anastamosis on hypersplenism. Dig Dis Sci 25:929-938, 1980
Hutson DG, Zeppa R, Levi J, et al: The effect of the distal splenorenal shunt on hypersplenism. Ann Surg 185:605-612, 1977
Frick V: Thrombocytopenie und lebercirrhose. Schweiz Med Wochenschr 97:407-413, 1967
Moschcowitz E: The pathogenesis of splenomegaly in hypertension of the portal circulation: “Congestive splenomegaly.” Medicine 27:187-221, 1948
MacPherson AIS, Innes J: Peripheral blood picture after operation for portal hypertension. Lancet 264:1120, 1953
Vang J, Simert G, Hansson JA, et al: Results of a modified distal spleno-renal shunt for portal hypertension. Ann Surg 185:224-228, 1977
Sullivan BH Jr, Tumen HJ: The effect of portocaval shunt on thrombocytopenia associated with portal hypertension. Ann Intern Med 22:598-603, 1961
Patton TB, Johnston CG, Lyons C, Jordan P Jr: Lateral portocaval anastomosis for portal hypertension. Am J Gastroenterol 32:291-310, 1959
Puttini M, Marni A, Montes F, Belli L: Effect of portasystemic shunt on hypersplenism. Clinical study in 129 patients with cirrhosis. Am Surg 45:444-448, 1979
Ferrara J, Ellison C, Martin EW, Cooperman M: Correction of hypersplenism following distal splenorenal shunt. Surgery 86:570-573, 1979
Malt RA. Portasystemic venous shunts. N Engl J Med 295:24-29, 1976
Marni A, Trojsi C, Belli L: Distal splenorenal shunt. Hemodynamic advantage over total shunt and influence on clinical status, hepatic function and hypersplenism. Am J Surg 142:372-376, 1981
Yanaga K, Tzakis A, Shimade M, Campbell W, et al: Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg 210:180-182, 1989
Hutchison DE, Genton E, Porter KA, et al: Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg 97:27-33, 1968
Rinkes IHMB, Van Der Hoop AG, Hesselink EJ, et al: Does auxiliary heterotopic liver transplantation reverse hypersplenism and portal hypertension? Gastroenterology 100:1126-1128, 1991
Thompson CB, Eaton KA, Princiotta SM, et al: Size dependent platelet subpopulations: Relationship of platelet volume to ultrastructure, enzymatic activity and function. Br J Haematol 50:509-519, 1982
Levin J, Bessman JD: The inverse relation between platelet volume and platelet number. Abnormalities in haematologic disease and evidence that platelet size does not correlate with platelet age. J Lab Clin Med 101:295-307, 1983
Karpatkin S, Freedman ML: Hypersplenic thrombocytopenia differentiated from increased peripheral destruction by platelet volume. Ann Intern Med 89:200-203, 1978
Van der Loo B, Martin JF: Megakaryocytes and platelets in vascular disease. Baillieres Clin Haematol 10:109-123, 1997
Conn HO: Transjugular intrahepatic portal-systemic shunts: The state of the art. Hepatology 17:148-158, 1993
Rossle M, Haag K, Ochs A, et al: The transjugular intrahepatic portosystemic stent-shunt for variceal bleeding. N Engl J Med 330:165-171, 1994
Jabbour N, Zajko A, Orons P, Irish W, et al: Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: Experience in candidate and noncandidate patient for liver transplantation. Liver Transplant Surg 2:139-147, 1996
LaBerge JM, Ring ER, Gordon RL, et al: Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: Results in 100 patients. Radiology 187:413-420, 1993
Karasu Z, Gurakar A, Jazzar A, McFadden R, Nour B, Sebastian A, Cassidy F, Stokes K, Kerwin B, Wright H: TIPS as a bridge to OLTx for patients with variceal hemorrhage and/or refractory ascites. Gastroenterology 116(suppl 2):A1228, 1999 (abstract)
Aster R: Pooling of platelets in the spleen: role in the pathogenesis of 'hypersplenic' thrombocytopenia. J Clin Invest 45:645-657, 1966
Heyns A duP, Lotter MG, Badenhorst PN, et al: Kinetics, distribution and sites of destruction of 111-indium-labelled human platelets. Br J Haematol 44:269-280, 1980
Peters AM, Klonizakis I, Lavender JP, Lewis SM: Use of 111-indium-labelled platelets to measure spleen function. Br J Heamatol 46:587-593, 1980
Peters AM, Lavender JP: Factors controlling the intrasplenic transit of platelets. Eur J Clin Invest 12:191-195, 1982
Wadenvik H, Denfors I, Kutti J: Splenic blood flow and intrasplenic platelet kinetics in relation to spleen volume. Br J Haematol 67:181-185, 1987
Peters AM: Splenic blood flow and blood cell kinetics. Clin Haematol 12:421-447, 1983
Heyns A duP, Badenhorst PN, Wessels P, Pieters H, Lotter MG: Kinetics, in vivo redistribution and sites of sequestration of indium-111-labelled platelets in giant platelet syndromes. Br J Haematol 60:323-330, 1985
Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA: The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology 23:32-39, 1996
Bowdler AJ: Splenomegaly and hypersplenism. Clin Haematol 12:467-488, 1983
Jandl JH, Aster RH: Increased splenic pooling and the pathogenesis of hypersplenism. Am J Med Sci 253:383-397, 1967
Tumen HJ: Hypersplenism and portal hypertension. Ann NY Acad Sci 170:332-340, 1970
Lawrence SP, Lezotte DC, Durham JD, Kumpe DA, Everson GT, Bilir BM: Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis. Dig Dis Sci 40:1575-1580, 1995
Alvarez OA, Lopera GA, Patel V, Encarnacion CE, Palmaz JC, Lee M: Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol 91:134-137, 1996
Bath PMW: The routine measurement of platelet size using sodium citrate alone as the anticoagulant. Thromb Haemost 70:687-690, 1993
Shulman NR, Watkins SP, Itscoitz SB, Students AB: Evidence that spleen retains youngest and haemostatically most effective platelets. Trans Assoc Am Physicians 81:302, 1968
Laufer N, Freund H, Charuzi I, et al: The influence of traumatic splenectomy on the volume of human platelets. Surg Gynecol Obstet 146:889-892, 1978
Wehmeier A, Scharf RE, Schneider W: Influence of splenectomy on platelet morphometry and function. Klin Woechenschr 68:847-852, 1990
Thomas HC, McSween RN, White RG: Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet 1:1288-1291, 1973
Triger DR, Wright R: Hyperglobulinemia in liver disease. Lancet 1:1494-1496, 1973
Landolfi R, Leone G, Fedeli G, Storti S, Laghi F, Bizzi B: Platelet-associated IgG in acute and chronic hepatic diseases. Scand J Hematol 25:417-422, 1980
DeNoronha R, Taylor BA, Wild G, Triger DR, Greaves M: Interrelationships between platelet count, platelet IgG, serum IgG, immun-complexes and severity of liver disease. Clin Lab Hematol 13:127-135, 1991
Skootsky SA, Rosove MH, Langley MB: Immune thrombocytopenia and response to splenectomy in chronic liver disease. Arch Intern Med 146:555-557, 1986
Paramo JA, Rocha E: Hemostasis in advanced liver disease. Semin Thromb Hemost 19:184-190, 1993
Sungaran R, Markovic B, Chong BH: Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow and spleen using in situ hybridization. Blood 89:101-107, 1997
Martin TG 3rd, Somberg KA, Meng YG, Cohen RL, Heid CA, de Sauvage FJ, Shuman MA: Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 127:285-288, 1997
Peck-Radosavljevic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Langle F, Steininger R, Muhlbacher F, Gangl A: Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver. J Hepatol 27:127-131, 1997
Ishikawa T, Ichida T, Matsuda Y, Sugitani S, Sugiyama M, Kato T, Miyazaki H, Asakura H: Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis. J Gastroenterol Hepatol 13:907-913, 1998
Stiegler G, Stohlawetz P, Peck-Radosavljevic M, Jilma B, Pidlich J, Wichlas M, Hocker P, Panzer S: Direct evidence for an increase in thrombopoiesis after liver transplantation. Eur J Clin Invest 28:755-759, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Karasu, Z., Gurakar, A., Kerwin, B. et al. Effect of Transjugular Intrahepatic Portosystemic Shunt on Thrombocytopenia Associated with Cirrhosis. Dig Dis Sci 45, 1971–1976 (2000). https://doi.org/10.1023/A:1005694617983
Issue Date:
DOI: https://doi.org/10.1023/A:1005694617983